Skip to content

Cart

Your cart is empty

Insights & News in Healthcare Safety

Balancing Disinfection and Manufacturer Recommendations in Ultrasound Technologies
Evidence-based Decision Making

Balancing Disinfection and Manufacturer Recommendations in Ultrasound Technologies

Introduction As the use of ultrasound technology continues to expand across various medical disciplines—from radiology and cardiology to point-of-care applications—ensuring appropriate and effectiv...

Read more
Five Key Takeaways on Video-Based Patient Monitoring for Preventing Falls
Evidence-based Decision Making

Five Key Takeaways on Video-Based Patient Monitoring for Preventing Falls

ECRI named ongoing challenges related to patient falls as one of its 2024 Top 10 Patient Safety Concerns because falls continue to be the number one sentinel event reported to the Joint Commission ...

Read more
Navigating the Evolving Landscape in Healthcare Value Analysis: Strategies for Success
Evidence-based Decision Making

Navigating the Evolving Landscape in Healthcare Value Analysis: Strategies for Success

The role of Value Analysis in Healthcare is pivotal as the industry faces constant change and transformation. Due to the nature of this complex specialty, it is necessary to illustrate and define a...

Read more
Using Evidence to Facilitate Physician-Patient Conversations about GLP-1 RAs
Evidence-based Decision Making

Using Evidence to Facilitate Physician-Patient Conversations about GLP-1 RAs

Glucagon-like peptide receptor agonists (GLP-1 RAs) now available to promote weight loss—Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide)—could potentially make much needed g...

Read more
Monitoring Patients Who Take GLP-1 RAs for Weight Loss – What Prescribers Should Know
Evidence-based Decision Making

Monitoring Patients Who Take GLP-1 RAs for Weight Loss – What Prescribers Should Know

Roughly one year after their introduction, Wegovy (semaglutide) and Zepbound (tirzepatide) continue to shake up the obesity treatment landscape in the United States. Uptake for these two glucagon-l...

Read more
Weighing the Evidence on New Weight Loss Drugs – Five Takeaways
Evidence-based Decision Making

Weighing the Evidence on New Weight Loss Drugs – Five Takeaways

The prevalence of overweight and obesity keeps worsening in America despite our enormous collective effort to lose weight. The U.S. Centers for Disease Control and Prevention estimates that overwei...

Read more
Bringing Everyone to the Table: Rapid Evidence Assessments Facilitate Meaningful Dialogue Across the Stakeholder Spectrum
Evidence-based Decision Making

Bringing Everyone to the Table: Rapid Evidence Assessments Facilitate Meaningful Dialogue Across the Stakeholder Spectrum

In the last two decades, the number of commercially available genetic tests is thought to have increased by more than 5,000%—from approximately 1,500 to an estimated 100,000 or more. This number on...

Read more
Increased Payer Support for Telemedicine May Improve Maternal Health Outcomes and Lower Costs
Evidence-based Decision Making

Increased Payer Support for Telemedicine May Improve Maternal Health Outcomes and Lower Costs

When compared to ten other developed nations, the United States has the highest maternal death rate. Yet, according to a recent maternal mortality review committee report by the Centers for Disease...

Read more